Long-term outcomes of postoperative radiotherapy for patients with pIIIA-N2 non-small-cell lung cancer after complete resection and adjuvant chemotherapy (PORT-C): a single-centre, randomized, phase 3 trial
National Key R&D Program of China, National Natural Science Foundation of China, Capital's Funds for Health Improvement and Research, Beijing Hope Run Special Fund of Cancer Foundation of China, and Beijing Xisike Clinical Oncology Research Foundation.
Authors
- Zhouguang Hui (ORCID: https://orcid.org/0000-0002-7189-4692)
- Zefen Xiao (ORCID: https://orcid.org/0000-0003-0503-6814)
- Lühua Wang (ORCID: https://orcid.org/0000-0002-5272-1681)
- Shugeng Gao (ORCID: https://orcid.org/0000-0003-1888-2622)
- Qinfu Feng (ORCID: https://orcid.org/0000-0003-0152-0879)
- Zongmei Zhou (ORCID: https://orcid.org/0000-0002-8336-2319)
- Junling Li (ORCID: https://orcid.org/0000-0002-7361-325X)
- Yu Men (ORCID: https://orcid.org/0000-0001-6956-7425)
- Nan Bi (ORCID: https://orcid.org/0000-0001-7201-2930)
- Jie Wang (ORCID: https://orcid.org/0000-0002-5602-0487)
- Jie He (ORCID: https://orcid.org/0000-0002-0285-5403)
- Yongxing Bao (ORCID: https://orcid.org/0000-0002-4178-4046)
- Jun Liang (ORCID: https://orcid.org/0000-0003-0309-0163)
- Jima Lv
- Yan Wang (ORCID: https://orcid.org/0000-0002-1743-6383)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- National Cancer Center (US)
Publication Details
- Journal
- EClinicalMedicine
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1016/j.eclinm.2025.103503
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Beijing Xisike Clinical Oncology Research Foundation
- National Natural Science Foundation of China
- Cancer Foundation of China